We are excited to announce that the 2026 Breakthrough T1D West Haven Walk will be powered by our incredible Presenting Sponsor, Yale New Haven Health! This organization shares our vision of a world ...

Islet cell therapies for type 1 diabetes (T1D) are in the works. In clinical trials, people are coming off external insulin—and experiencing healthy blood sugar levels. Researchers and clinicians are ...

Nancy Adleman’s journey with Breakthrough T1D began when her daughter was diagnosed with type 1 diabetes at just 13 months old in late 2020 — an experience that inspired her to support other T1D ...

Due to the extreme weather conditions expected this weekend, our venue partners and staff have made the difficult decision to cancel the Breakthrough T1D Boston (9/26) and Maine (9/27) Walks. Your ...

The FDA approved finerenone to slow kidney disease progression in adults with chronic kidney disease and type 1 diabetes.

Encellin, Inc., a clinical-stage biotechnology company developing Encapsulated Cell Replacement Therapy (ENCRT), today announced a partnership with Breakthrough T1D, the leading global Type 1 Diabetes ...

Breakthrough T1D applauds today’s approval by the U.S. Food and Drug Administration (FDA) of the drug finerenone (Kerendia™/Firialta™) as the first new therapy that can treat chronic kidney disease ...

Breakthrough T1D Walk is a nationwide movement dedicated to raising type 1 diabetes (T1D) awareness and funding research.

Today, the Congressional Diabetes Caucus announced Congresswoman Kim Schrier (D-WA) as their next Co-chair, filling the role held by Congresswoman Diana DeGette (D-CO) since 1999. Breakthrough T1D ...

Help us to grow our community by sharing with yours: Breakthrough T1D Overview T1D Resources Library Careers Discover Events News And Updates Contact Us Donate ...

I am Asher Stanley’s Nana. He is six years old, and two years ago he was diagnosed with type 1 diabetes. It changed all of our lives. But Asher has not missed a beat. He is still the same sweet, funny ...